Artisan Partners Limited Partnership Acquires 21,042 Shares of CME Group Inc. (NASDAQ:CME)

Artisan Partners Limited Partnership lifted its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 4.2% during the fourth quarter, HoldingsChannel reports. The firm owned 524,885 shares of the financial services provider’s stock after purchasing an additional 21,042 shares during the period. Artisan Partners Limited Partnership’s holdings in CME Group were worth $121,894,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider’s stock worth $7,952,273,000 after acquiring an additional 326,623 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of CME Group by 1.8% in the third quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after purchasing an additional 142,692 shares during the period. Raymond James Financial Inc. bought a new position in CME Group in the fourth quarter worth approximately $871,063,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its holdings in CME Group by 3.3% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,054,380 shares of the financial services provider’s stock worth $710,143,000 after purchasing an additional 96,301 shares during the period. Finally, Janus Henderson Group PLC raised its position in CME Group by 17.8% during the 3rd quarter. Janus Henderson Group PLC now owns 2,514,040 shares of the financial services provider’s stock valued at $554,707,000 after purchasing an additional 380,071 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Morgan Stanley boosted their price target on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a report on Wednesday, February 19th. Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price objective on the stock in a research note on Monday, March 10th. Oppenheimer boosted their price objective on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Finally, JPMorgan Chase & Co. increased their target price on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research report on Thursday, February 13th. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $238.93.

View Our Latest Stock Report on CME Group

CME Group Price Performance

Shares of NASDAQ CME opened at $261.85 on Friday. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $267.91. The company has a market cap of $94.36 billion, a PE ratio of 27.08, a P/E/G ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The business has a 50-day simple moving average of $249.06 and a two-hundred day simple moving average of $235.32.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.91%. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. CME Group’s dividend payout ratio is presently 51.71%.

CME Group declared that its board has authorized a share buyback plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Insider Buying and Selling

In related news, insider Julie Winkler sold 11,592 shares of the stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total value of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,076 shares of company stock worth $6,871,496 in the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.